000 01339 a2200397 4500
005 20250513124001.0
264 0 _c19971009
008 199710s 0 0 eng d
022 _a0960-8966
024 7 _a10.1016/s0960-8966(97)00058-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilton, S D
245 0 0 _aRevertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
_h[electronic resource]
260 _bNeuromuscular disorders : NMD
_cJul 1997
300 _a329-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDystrophin
_xgenetics
650 0 4 _aExons
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Inbred mdx
_xgenetics
650 0 4 _aMuscle Fibers, Skeletal
_xmetabolism
650 0 4 _aMuscular Dystrophy, Animal
_xgenetics
650 0 4 _aMutation
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aSensitivity and Specificity
650 0 4 _aTranscription, Genetic
700 1 _aDye, D E
700 1 _aBlechynden, L M
700 1 _aLaing, N G
773 0 _tNeuromuscular disorders : NMD
_gvol. 7
_gno. 5
_gp. 329-35
856 4 0 _uhttps://doi.org/10.1016/s0960-8966(97)00058-8
_zAvailable from publisher's website
999 _c9247427
_d9247427